Marah C. Runtsch
152-160 Pearse Street, Dublin D02 R590
Dublin, L, Ireland
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.
Journal: Science translational medicine
Published: November 26, 2025
Adenosine 2A receptor-dependent activation of AMPK represses TH17 cell pathogenicity through epigenetic and metabolic reprogramming.
Journal: Science signaling
Published: September 23, 2025
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis.
Journal: EBioMedicine
Published: May 23, 2025
Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion.
Journal: Science advances
Published: January 22, 2025
Targeting myeloid cell immunometabolism to improve current non-small cell lung cancer therapies.
Journal: Pharmacology & therapeutics
Published: November 18, 2024
Myeloperoxidase Alters Lung Cancer Cell Function to Benefit Their Survival.
Journal: Antioxidants (Basel, Switzerland)
Published: May 10, 2023
Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages.
Journal: Cell metabolism
Published: June 23, 2021
Metabolic determinants of leukocyte pathogenicity in neurological diseases.
Journal: Journal of neurochemistry
Published: June 14, 2020
A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages.
Journal: Nature communications
Published: May 05, 2020
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation.
Journal: Cell metabolism
Published: April 21, 2020
Last Updated: 09/26/2026